Key result
Hsp22 deletion in mice exposed to pressure overload accelerated the transition into heart failure and increased mortality by impairing nuclear and mitochondrial functions of STAT3.
Why the study?
Does Hsp22 deletion accelerate the transition into heart failure in a mouse model of cardiac pressure overload?
Does Hsp22 deletion accelerate the transition into heart failure in a mouse model of cardiac pressure overload?
Hsp22 is a novel activator of nuclear and mitochondrial STAT3 functions, and its deletion accelerates heart failure and mortality during pressure overload.
No takes yet. Share an insight, caveat, or question.
No immediate clinical implications from mouse data; leaves open Hsp22-STAT3 as a therapeutic target for future study.
Qiu et al. (2011) studied Cardiac overload and heart failure. Hsp22 deletion vs. Wild-type mice was evaluated on Transition into heart failure and mortality. Hsp22 deletion in mice exposed to pressure overload accelerated the transition into heart failure and increased mortality by impairing nuclear and mitochondrial functions of STAT3.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: